DeepMed Research

Integra LifeSciences Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers

Phase 3

Terminated

Conditions: Diabetic Foot Ulcers

Interventions: Drug: DSC127
Drug: placebo vehicle gel
Drug: Standard of Care gel, Aquasite

First Posted Date: 2013-05-09

Last Posted Date: 2017-12-12

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 396

Registration Number: NCT01849965

Locations: 🇺🇸
East Valley Foot and Ankle Specialist, Mesa, Arizona, United States
🇺🇸
Research in Miami, Inc., Hialeah, Florida, United States
🇺🇸
Bluegrass Foot Center c/o Research Concierge, LLC, Owensboro, Kentucky, United States

and more 52 locations

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Phase 3

Terminated

Conditions: Diabetic Foot Ulcer

Interventions: Drug: 0.03% DSC127 topical gel

First Posted Date: 2013-04-25

Last Posted Date: 2017-12-12

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 261

Registration Number: NCT01840085

Locations: 🇺🇸
Orange County Research Center, Tustin, California, United States
🇺🇸
WILMAX Clinical Research, Mobile, Alabama, United States
🇺🇸
GF Professional Research, Miami Lakes, Florida, United States

and more 18 locations

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Phase 3

Terminated

Conditions: Diabetic Foot Ulcers

Interventions: Drug: placebo vehicle gel
Drug: DSC127

First Posted Date: 2013-04-12

Last Posted Date: 2017-12-12

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 266

Registration Number: NCT01830348

Locations: 🇺🇸
Center for Clinical Research, Portland, Oregon, United States
🇺🇸
UF Health Orthopaedic Surgery Clinic, Jacksonville, Florida, United States
🇺🇸
Brian O'Carroll, DPM, Inc., Pismo Beach, California, United States

and more 21 locations

Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant

Completed

Conditions: Surgery

Interventions: Procedure: craniectomy

First Posted Date: 2013-04-05

Last Posted Date: 2018-07-02

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 110

Registration Number: NCT01824706

Locations: 🇫🇷
CHU Henri Mondor, Créteil, France
🇫🇷
CHU Angers, Angers, France
🇫🇷
CH de la cote basque, Bayonne, France

and more 15 locations

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix

Not Applicable

Terminated

Conditions: Foot Ulcer, Diabetic

Interventions: Other: Standard of Care Moist Wound Therapy
Device: PriMatrix Moist Wound Therapy

First Posted Date: 2012-11-20

Last Posted Date: 2016-10-18

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 92

Registration Number: NCT01729286

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Foot and Ankle Clinic, Los Angeles, California, United States
🇺🇸
Advanced Research Institute of Miami, Miami, Florida, United States

and more 15 locations

Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)

Not Applicable

Completed

Conditions: Recurrent Acute Rhinosinusitis

Interventions: Device: balloon sinus dilation
Other: medical therapy

First Posted Date: 2012-10-26

Last Posted Date: 2024-07-12

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 59

Registration Number: NCT01714687

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

Completed

Conditions: Sinusitis

Interventions: Device: Balloon sinus dilation
Drug: Medical Management

First Posted Date: 2012-09-14

Last Posted Date: 2024-07-12

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 198

Registration Number: NCT01685229

A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers

Not Applicable

Terminated

Conditions: Venous Stasis Ulcer

Interventions: Device: PriMatrix
Device: PriMatrix Ag
Procedure: moist wound therapy

First Posted Date: 2012-06-06

Last Posted Date: 2024-04-01

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 31

Registration Number: NCT01612806

Locations: 🇵🇷
Caribbean Clinical Trials, San Juan, Puerto Rico
🇵🇷
Dr. Pila Metropolitan Hospital Wound Healing Center, Ponce, Puerto Rico
🇵🇷
Doctors' Center Hospital of San Juan, San Juan, Puerto Rico

and more 2 locations

Earset Healthy Volunteer Study

Completed

Conditions: Otitis Media

Interventions: Device: Iontophoresis System With Earset

First Posted Date: 2012-06-04

Last Posted Date: 2024-07-11

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 22

Registration Number: NCT01611246

Locations: 🇺🇸
CEI Medical Group, East Palo Alto, California, United States

Tympanostomy Tube Placement in Children in the Office (Inova Study)

Not Applicable

Completed

Conditions: Otitis Media

Interventions: Device: Tube Delivery System (TDS)

First Posted Date: 2011-12-21

Last Posted Date: 2024-08-06

Lead Sponsor: Integra LifeSciences Corporation

Target Recruit Count: 70

Registration Number: NCT01496287

Locations: 🇺🇸
South Coast Ear, Nose & Throat, Port Saint Lucie, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy